Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001562180-22-004545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-27 | 2022-05-25 | FHTX | Bellon Steven F. | CSO | M - OptEx | $3.26 | +4,392 | 120.1K | +4% | +$14.3K |
| DM | 2022-05-27 | 2022-05-25 | FHTX | Bellon Steven F. | CSO | M - OptEx | $0.00 | -4,392 | 5,574 | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-25 | M | A | 675 | $0.73 | 116,382 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-25 | M | A | 3,717 | $3.72 | 120,099 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2022-05-25 | M | D | 675 | $0.00 | 0 | D | $0.73 · — to 2028-01-30 | 675 Common Stock | (F2) The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested. |
| 4 | Derivative | Stock Options (Right to buy) | 2022-05-25 | M | D | 3,717 | $0.00 | 5,574 | D | $3.72 · — to 2029-02-13 | 3,717 Common Stock | (F3) The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. |